Cadrenal Therapeutics Inc (CVKD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2017 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 10,018 | 8,403 | 33 | N/A |
| Receivables | 38 | 37 | N/A | N/A |
| Other current assets | 14 | 0 | 672 | 0 |
| TOTAL | $10,113 | $8,492 | $728 | $N/A |
| Non-Current Assets | ||||
| PPE Net | 7 | 2 | 1 | N/A |
| Other Non-Current Assets | 4 | 25 | 50 | 0 |
| TOTAL | $11 | $27 | $51 | $N/A |
| Total Assets | $10,124 | $8,519 | $778 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 1,503 | 167 | 405 | 0 |
| Accrued Expenses | 1,182 | 638 | 864 | N/A |
| TOTAL | $2,684 | $827 | $1,335 | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 0 | 0 | 4,995 | 0 |
| TOTAL | $N/A | $N/A | $4,995 | $N/A |
| Total Liabilities | $2,684 | $827 | $6,329 | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 1,880 | 1,068 | 776 | N/A |
| Common Shares | 2 | 1 | 8 | N/A |
| Retained earnings | -25,723 | -15,071 | -6,714 | N/A |
| TOTAL | $7,440 | $7,692 | $-5,551 | $N/A |
| Total Liabilities And Equity | $10,124 | $8,519 | $778 | $0 |